2-acetyl-4(5)-tetrahydroxybutylimidazole has been researched along with MS (Multiple Sclerosis) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beerli, C; Bergsdorf, C; Billich, A; Braendlin, N; Oberhauser, B; Schubart, A; Srinivas, H; Weiler, S | 1 |
1 other study(ies) available for 2-acetyl-4(5)-tetrahydroxybutylimidazole and MS (Multiple Sclerosis)
Article | Year |
---|---|
Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
Topics: Administration, Oral; Aldehyde-Lyases; Animals; Catalytic Domain; Cells, Cultured; Crystallography, X-Ray; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Male; Models, Molecular; Multiple Sclerosis; Mutation; Phthalazines; Protein Conformation; Pyridines; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship | 2014 |